Governance Cizzle Biotechnology Holdings Plc

PSL

GB00BNG2VN02

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 10:05:27 13/02/2026 pm IST			5-day change	1st Jan Change
1.350 ^GBX	-12.90%		-12.90%	-12.90%

04/02	Cizzle secures Canadian patent for lung cancer test format	AN
04/02	Cizzle Biotechnology Lung Cancer Test Secures Patent in Canada	MT

Executive Committee: Cizzle Biotechnology Holdings Plc

Manager

Positions heldSince

Dawn Coverley

61 year

Chief Tech/Sci/R&D Officer

02/01/2025

Nigel Lee

65 year

Director of Finance/CFO

14/05/2021

Composition of the Board of Directors: Cizzle Biotechnology Holdings Plc

Director

CommitteesSince

Allan Syms

69 year

Chairman

21/05/2019

John Treacy

44 year

Audit Committee Chair
Compensation Committee Chair	14/07/2021
Audit Committee	14/07/2021
Nominating Committee Chair
Compensation Committee

Edwin Bower

60 year

Audit Committee	25/03/2025
Organization Committee	25/03/2025

Dawn Coverley

61 year

Audit Committee	14/05/2021
Compensation Committee	14/05/2021

Nigel Lee

65 year

Director/Board Member

14/05/2021

Latest Appointments: Cizzle Biotechnology Holdings Plc

25/25/25	Cizzle Biotechnology Holdings Plc Announces Board and Committee Changes	CI
02/25/02	Cizzle Biotechnology appoints Founder Dawn Coverley as CSO	AN
02/25/02	Cizzle Biotechnology Appoints Chief Scientific Officer	MT
02/25/02	Cizzle Biotechnology Holdings plc Appoints Dawn Coverley as Chief Scientific Officer	CI
02/24/02	MaxCyte inks deal with Be Bio; Orcadian firms farmout	AN
27/23/27	Ceiba net asset value down, up for Asia Dragon Trust	AN
23/22/23	TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact	AN

More news

Former Officers and Directors: Cizzle Biotechnology Holdings Plc

Insider

Positions held

SinceUntil

Martin Lampshire

Director/Board Member

11/01/2019

14/05/2021

Jonathan Freeman

Director/Board Member	28/03/2012	12/05/2015
Chairman	12/04/2015	21/05/2019
Independent Dir/Board Member	28/03/2012	21/05/2019

James Stuart McKenzie

Director/Board Member	01/03/2007	31/01/2019
Chief Executive Officer	01/03/2007	31/01/2019
Founder	01/03/2007	31/01/2019

Majd E. Zoorob

Director/Board Member	01/03/2007	22/01/2019
Chief Tech/Sci/R&D Officer	01/03/2007	22/01/2019
Founder	01/03/2007	22/01/2019

Philip Marshall

Director/Board Member

02/08/2013

01/01/2016

Andrew Nelson

Director/Board Member	12/05/2015	08/12/2015
Chairman	29/12/2010	12/05/2015

Russell Banks

Director/Board Member	02/04/2013	29/01/2015
Director of Finance/CFO	02/04/2013	29/01/2015

David McTurk

Chief Operating Officer

29/10/2014

Bryan Lawrence

Corporate Officer/Principal

29/10/2014

David John Holloway

Corporate Officer/Principal

03/09/2012

02/04/2013

Ceri Marc Jones

Director/Board Member	29/12/2010	25/05/2012
Director of Finance/CFO	29/12/2010	25/05/2012

Fenella Frost

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	5
Female	0

Of which Executive Committee

Male	2
Female	0

Of which Directors

Male	5
Female	0

Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable plasma biomarker, a variant of CIZ1 known as CIZ1B. CIZ1 is a cell nuclear protein involved in deoxyribonucleic acid (DNA) replication, and the targeted CIZ1B variant is correlated with early-stage lung cancer. Its prototype confirmative test has been developed to address the false positive rates of computed tomography (CT) scanning. The test is intended to address a clear unmet clinical need, which is early detection of lung cancer, when curative surgical resection is possible.

Employees

Sector

Biotechnology & Medical Research

More about the company